Analyzing the Estrogen Receptor Status of Liver Metastases with [<sup>18</sup>F]-FES-PET in Patients with Breast Cancer

Analyzing the Estrogen Receptor Status of Liver Metastases with [<sup>18</sup>F]-FES-PET in Patients with Breast Cancer

Background: Positron emission tomography (PET) with 16α-[<sup>18</sup>F]-fluoro-17β-estradiol ([<sup>18</sup>F]-FES) can visualize estrogen receptor (ER) expression, but it is challenging to determine the ER status of liver metastases, due to high physiological [<sup>18...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jorianne Boers, Naila Loudini, Robbert J. de Haas, Antoon T. M. Willemsen, Bert van der Vegt, Elisabeth G. E. de Vries, Geke A. P. Hospers, Carolina P. Schröder, Andor W. J. M. Glaudemans, Erik F. J. de Vries
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
FES-PET/CT
breast cancer
liver metastases
estrogen receptor
quantification
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/55c90a5881014d0d86ff8c95e773378a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/55c90a5881014d0d86ff8c95e773378a

Ejemplares similares